Immunosuppressive Induction Agents in Liver Transplantation: No Impact on Incisional Hernia Development

Despite the technical complexity of liver transplantation and the high incidence of incisional hernias, a retrospective cohort study found that the specific immunosuppressive induction agent administered during surgery did not affect the development of hernias. However, obesity and postoperative seroma of the abdominal wall were identified as potential risk factors. The overall incisional hernia rate at 5 years post-transplantation was 28.5%, highlighting the need for further research to validate these findings across different settings.